Startups
Impiricus Is Aiming to Become Physicians’ One-Stop Shop for Pharma Engagement
Over the past few years, even before COVID, physicians have been forced to deal ...
PatientPartner Serves as a Patient’s Friend Through the Surgery Process
When patients are about to have a surgery, they have a ton of questions ...
Cambrian is Using a New Drug Discovery Model to Solve the Science of Aging
James Peyer knows the venture capital (VC) model for building new biotech companies well. ...
Clene is Using Nanocrystals of Pure Elements to Change Neurodegenerative Treatment
As our brains age, our neurons shrink and lose energy making it harder for ...
Anima Biotech’s mRNA Technology is Lighting Up Novel Drug Targets
Thanks to the Pfizer/BioNTech and Moderna COVID-19 vaccines, it is likely you have heard ...
Purohit Ventures Enters the Healthcare Investment Space with Unique Model
Investments continue to flow into healthcare at a record pace, with the third quarter ...
Vineti Is Streamlining the Supply Chain for Personalized Therapies
Personalized medicine—such as cell and gene therapies (CGT) and personalized cancer vaccines—are completely changing ...
The BioInnovation Institute on the Life Sciences Investment Market and How Startups Can Succeed
Innovation never sleeps in the life sciences industry, and investors are putting more money ...
Thrive Earlier Detection Can Make Cancer More Curable
If cancer is caught early enough, it can often be effectively treated or even ...
Cerevance Is Exploring the Brain at Depths Never Before Possible
Neurodegenerative and other central nervous system disorders are some of the hardest to develop ...
Medable is Working to Cut Clinical Research Timelines in Half
The current COVID-19 pandemic has put a huge spotlight on the life sciences industry’s ...
Paige is Using its Vast Access to Data and AI to Transform Pathology and Drug Development
For artificial intelligence (AI) to be truly effective it needs data—and lots of it, ...
Inzata Aims to Make Data Analytics Easy for Everyone
Data, what is it good for? Absolutely nothing if 90% of the data being ...